Clinical Trials Logo
  1. Home
  2. Gastritis
  3. NCT03980756

A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

Gastritis Clinical Trial

Official title:
A Randomized, Open-label, Multiple-dose, Crossover Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of AD-206 to Esomeprazole in Healthy Male Volunteers

Clinical Trial Summary

A study to compare safety, pharmacokinetics and pharmacodynamics of AD-206 to Esomeprazole in healthy male volunteers.

Clinical Trial Description

This study is to compare the safety, pharmacokinetic characteristics and pharmacodynamic characteristics of AD-206 compared with administration of Esomeprazole in healthy male subjects. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03980756
Study type Interventional
Source Addpharma Inc.
Contact
Status Completed
Phase Phase 1
Start date June 5, 2019
Completion date June 18, 2020
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04289519 - Endoscopic Findings of Gastritis in Children
Recruiting NCT02353039 - Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis Phase 2
Recruiting NCT05545397 - Sedation Level on Machine Learning With Electroencephalogram in Painless Gastroenteroscopy Patients
Not yet recruiting NCT05510388 - HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients N/A
Completed NCT02724280 - Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy N/A
Not yet recruiting NCT02961296 - Helicobacter Pylori Antibiotic Susceptibility Testing of Korea N/A
Completed NCT02385045 - i-Scan for the Detection of Helicobacter Pylori N/A
Completed NCT00212225 - Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori) N/A
Completed NCT04672018 - Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis Phase 2
Not yet recruiting NCT05072938 - Phase IV Clinical Trial to Compare the Efficacy and Safety of Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis Phase 4
Completed NCT02597517 - New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric Atrophy N/A
Completed NCT02296021 - Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy Phase 4
Completed NCT01576289 - Analysis of Biopsies From the Upper Gastrointestinal Tract N/A
Active, not recruiting NCT03509831 - [KJ-INT-002] BE Study Phase 1
Terminated NCT05579444 - Systems Biology of Gastrointestinal and Related Diseases
Suspended NCT04306939 - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Completed NCT05237115 - Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy Phase 4
Completed NCT02393430 - Clinical Effect of Rebamipide on Chronic Gastritis Phase 4
Completed NCT00579410 - Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule N/A
Completed NCT00267475 - Data Bank for Eosinophilic Disorders N/A